SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Completed · Phase 3

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether SU-101 is more effective than procarbazine in treating patients with glioblastoma multiforme. PURPOSE: Randomized phase III trial to compare the effectiveness of SU-101 with that of procarbazine in treating patients with glioblastoma multiforme that has recurred.

Key facts

Study ID

NCT00003293

Run by

Pfizer

Starts

1998-02-01

Expected to finish

2001-05-01

Last updated by the study team

2012-09-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
• Arizona Cancer Center — Tucson, Arizona, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Beckman Research Institute, City of Hope — Los Angeles, California, United States
• St. Francis Hospital — San Francisco, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Medical College of Georgia Hospital and Clinics — Augusta, Georgia, United States
• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• University of Iowa College of Medicine — Iowa City, Iowa, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Cancer Center of Albany Medical Center — Albany, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Herbert Irving Comprehensive Cancer Center — New York, New York, United States
• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Barrett Cancer Center, The University Hospital — Cincinnati, Ohio, United States
• Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.